PMID- 10684010 OWN - NLM STAT- MEDLINE DCOM- 20000414 LR - 20161020 IS - 0257-7712 (Print) IS - 0257-7712 (Linking) VI - 29 IP - 2 DP - 1998 Jun TI - [Relationship between tumor cell proliferating activity and biological behavior, prognosis in laryngeal carcinoma]. PG - 178-81 AB - Using PC 10, an antibody to proliferating cell nuclear antigen (PCNA) and a standard immunohistochemical staining the authors examined 11 cases of simple hyperplasia of epithelium (SHE), 32 cases of atypical hyperplasia of epithelium (AHE) and 42 cases of laryngeal squamous cell carcinoma (LSCC) for expression of PCNA, a protein associated with DNA polymerase dalta and DNA replication, a marker for tumor cell proliferation. The results revealed that PCNA indices in SHE, AHE and LSCC were 9.5%, 27.33% and 68.05%, respectively. The PCNA indices were 63.68%, 69.57%, 71.18% in the well, moderately and poorly differentiated LSCC, respectively, there were significant differences. The PCNA indices were 63.88%, 70.82%, 66.20% and 69.04%, respectively in stages I, II, III, and IV of LSCC; no significance was found. There was a strong negative correlation betwee survival time and the tumor cell proliferative activity (r = 0.6243). PCNA might provide a useful tool for studying cell proliferation in situ under normal and pathological condition. FAU - Zhou, G AU - Zhou G AD - Department of Otolaryngology, First Affiliated Hospital, Chengdu. FAU - Liang, C AU - Liang C FAU - Lin, D AU - Lin D FAU - Zhang, X AU - Zhang X FAU - Wen, D AU - Wen D FAU - Liu, Y AU - Liu Y LA - chi PT - English Abstract PT - Journal Article PL - China TA - Hua Xi Yi Ke Da Xue Xue Bao JT - Hua xi yi ke da xue xue bao = Journal of West China University of Medical Sciences = Huaxi yike daxue xuebao JID - 8609552 RN - 0 (Proliferating Cell Nuclear Antigen) SB - IM MH - Adult MH - Aged MH - Carcinoma, Squamous Cell/*pathology/secondary MH - Female MH - Humans MH - Hyperplasia MH - Immunohistochemistry MH - Laryngeal Neoplasms/*pathology MH - Laryngectomy MH - Larynx/*pathology MH - Lymphatic Metastasis MH - Male MH - Middle Aged MH - Neoplasm Staging MH - Precancerous Conditions/*pathology MH - Proliferating Cell Nuclear Antigen/metabolism MH - Survival Rate EDAT- 2000/02/23 09:00 MHDA- 2000/04/25 09:00 CRDT- 2000/02/23 09:00 PHST- 2000/02/23 09:00 [pubmed] PHST- 2000/04/25 09:00 [medline] PHST- 2000/02/23 09:00 [entrez] PST - ppublish SO - Hua Xi Yi Ke Da Xue Xue Bao. 1998 Jun;29(2):178-81.